Stay updated on ORION-01 Oregovomab & Nivolumab Clinical Trial
Sign up to get notified when there's something new on the ORION-01 Oregovomab & Nivolumab Clinical Trial page.

Latest updates to the ORION-01 Oregovomab & Nivolumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision tag, Revision: v3.4.2, was added. The prior notices and revision tag, Revision: v3.4.1, were removed along with a government-funding/operating-status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA new site notice about possible delays due to a lapse in government funding has been added, and the revision label updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary feature added and metadata labels updated (e.g., Revision: v3.4.0) with minor capitalization changes. These changes are cosmetic and do not affect study details, eligibility criteria, outcomes, or core functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated to v3.3.4 and the previous v3.3.3 revision note removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedFooter now displays Revision: v3.3.3, and the HHS Vulnerability Disclosure link as well as Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedMinor revision label updated from v3.3.1 to v3.3.2; core study details and eligibility information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ORION-01 Oregovomab & Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ORION-01 Oregovomab & Nivolumab Clinical Trial page.